about
Rv2969c, essential for optimal growth inMycobacterium tuberculosis, is a DsbA-like enzyme that interacts with VKOR-derived peptides and has atypical features of DsbA-like disulfide oxidasesQuorum sensing and biofilm formation in mycobacteria: role of c-di-GMP and methods to study this second messengerSystems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of TuberculosisDelayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism.Genome-wide Mycobacterium tuberculosis variation (GMTV) database: a new tool for integrating sequence variations and epidemiology.Potential of Zanthoxylum leprieurii as a source of active compounds against drug resistant Mycobacterium tuberculosis.Network analysis identifies Rv0324 and Rv0880 as regulators of bedaquiline tolerance in Mycobacterium tuberculosis.Inhibition of the first step in synthesis of the mycobacterial cell wall core, catalyzed by the GlcNAc-1-phosphate transferase WecA, by the novel caprazamycin derivative CPZEN-45MmpL3 a potential new target for development of novel anti-tuberculosis drugs.Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering.Importance of specimen pretreatment for the low-level detection of mycobacterial lipoarabinomannan in human serum.Glyconanomaterials for Combating Bacterial Infections.Novel drug targets for Mycobacterium tuberculosis: 2-heterostyrylbenzimidazoles as inhibitors of cell wall protein synthesis.Resistant TB: Use the tools available.Suramin is a potent and selective inhibitor of Mycobacterium tuberculosis RecA protein and the SOS response: RecA as a potential target for antibacterial drug discovery.Resistant TB: Remove cultural barriers
P2860
Q27680167-9B15B7B3-B103-452C-99E9-75CABE1D7113Q28082326-BED01A59-033D-446F-A435-14F74FC26910Q28649769-49B268B7-3164-4E51-A325-6D087061DC92Q30573771-1521628F-FA1F-4CCA-857B-3E95D97E8ADBQ35157690-E84088B3-3C04-46A2-B7F6-C30D154E66D1Q36266759-BEDC4424-63BA-4083-9CE6-B0E04DE4FDCEQ37229500-15AD23FD-EFDC-4788-9CFD-188C9D8C7793Q37234023-B65ED538-3800-45F1-92A8-D2220A4C5788Q38170188-0FB50DC9-F488-4C60-84CA-A322F75FA0D7Q38325342-D103369C-E1CE-4D7F-8CD6-4B80C5335395Q38376927-F77DF3C2-B61E-4E58-91AB-3C6267DE821BQ40416538-877414A2-34B0-4DCD-9FF5-A36C4CFF4017Q40975640-A57EBB72-07C4-4304-AB4A-319BCB564F77Q42919818-695E8F69-4CC3-4364-BFF7-057FC12B83E2Q43432504-45624918-9991-4DC1-A410-CCC1D366761AQ43633453-857B6414-886D-4BF5-BE59-36217A82AA93Q74437461-884AA2A8-5175-4EF6-9B15-A56304647C37
P2860
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в січні 2013
@uk
name
Infectious disease: TB's revenge
@en
Infectious disease: TB's revenge
@nl
type
label
Infectious disease: TB's revenge
@en
Infectious disease: TB's revenge
@nl
prefLabel
Infectious disease: TB's revenge
@en
Infectious disease: TB's revenge
@nl
P356
P1433
P1476
Infectious disease: TB's revenge
@en
P2093
Leigh Phillips
P2888
P356
10.1038/493014A
P407
P577
2013-01-01T00:00:00Z
P6179
1045600528